Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters








Year range
1.
Chinese Journal of Contemporary Pediatrics ; (12): 708-710, 2008.
Article in Chinese | WPRIM | ID: wpr-317351

ABSTRACT

<p><b>OBJECTIVE</b>To study the effects of different models of mechanical ventilation on inflammatory cytokines, IL-6, IL-10 and TNF-alpha, in children after cardiopulmonary bypass (CPB).</p><p><b>METHODS</b>Sixty patients who underwent CPB were randomly divided into group A and group B. After CPB, group A was ventilated with high tidal volume (VT, 10-12 mL/kg) /low positive end-expiratory pressure (PEEP, 3-5 cm H2O), while group B was ventilated with low VT (6-8 mL/kg) /high PEEP (6-9 cm H2O). Plasma levels of IL-6, IL-10 and TNF-alpha were measured before operation, at the end of the operation, and 1 and 6 hrs after operation.</p><p><b>RESULTS</b>Serum levels of IL-6, IL-10 and TNF-alpha in both groups increased significantly at the end of the operation and reached a peak by 1 hr after operation. Group B showed lower serum levels of IL-6, IL-10 and TNF-alpha than group A 1 and 6 hrs after operation.</p><p><b>CONCLUSIONS</b>Mechanical ventilation with low VT /high PEEP may more effectively inhibit the release of inflammatory cytokines than that with high VT /low PEEP in children after CPB.</p>


Subject(s)
Female , Humans , Infant , Male , Cardiopulmonary Bypass , Interleukin-10 , Blood , Interleukin-6 , Blood , Respiration, Artificial , Tumor Necrosis Factor-alpha
2.
Journal of Central South University(Medical Sciences) ; (12): 313-318, 2006.
Article in English | WPRIM | ID: wpr-813707

ABSTRACT

OBJECTIVE@#To create a method for transfecting human vascular endothelial growth factor165 (hVEGF165) gene into bone marrow mesenchymal stem cells (MSCs) in rats.@*METHODS@#MSCs of Wistar rats were isolated by density gradient centrifugation and purified based on their ability of adhesion to plastic. Detections of cell surface antigens, including CD34, CD45, CD44, and SH3, were performed using flow cytometry. MSCs' potential of differentiating into osteoblast and lipoblast in vitro was tested. The vector pcDNA(3.1)-hVEGF165 was transfected into MSCs with the liposome mediated method. The expression of hVEGF165 in the transfected cells was detected by enzyme linked immunosorbent assay (ELISA), reverse transcription-polymerase chain reaction (RT-PCR), and Western blot analysis.@*RESULTS@#The cultured MSCs were CD34-, CD45-, CD44+ , and SH+, which were differentiated into osteoblasts and lipocytes successfully. The expressed hVEGF165 in the transfected rat MSCs was demonstrated.@*CONCLUSION@#The vector pcDNA(3.1)-hVEGF165 is successfully expressed in MSCs.


Subject(s)
Animals , Humans , Rats , Antigens, CD34 , Bone Marrow Cells , Cell Biology , Cell Differentiation , Physiology , Cells, Cultured , Hyaluronan Receptors , Leukocyte Common Antigens , Mesenchymal Stem Cells , Cell Biology , Metabolism , Rats, Wistar , Transfection , Vascular Endothelial Growth Factor A , Genetics
3.
Journal of Central South University(Medical Sciences) ; (12): 763-771, 2006.
Article in Chinese | WPRIM | ID: wpr-813603

ABSTRACT

OBJECTIVE@#To evaluate the angiogenic effect of the bone marrow mesenchymal stem cells (MSCs) transfected with human vascular endothelial growth factor (VEGF(165)) gene on myocardial infarcts in rats.@*METHODS@#The animal model of heart ischemic was established by ligating the left anterior descending coronary artery in Wistar rats. The ligated rats were divided into 4 groups (n=12 each), and 2 weeks later they were injected hVEGF-transfected MSC at the heart infarct zone (Group A), MSC (Group B), liposome-hVEGF gene plasmid (Group C), and medium (Group D). Four weeks after the injection, the capillary density of the infracted zone and the expression of human VEGF in vivo were examined.@*RESULTS@#Four weeks after the transplantation,the capillary density was significantly greater in Group A than that in Group B and Group D, slightly greater than that in Group C. The highest expression of hVEGF was Group A, and followed by Group C, Group B, and Group D.@*CONCLUSION@#MSC is helpful for the stable expression of hVEGF gene, and is an ideal cellular vehicle for VEGF genes.


Subject(s)
Animals , Humans , Male , Rats , Bone Marrow Cells , Cell Biology , Coronary Circulation , Mesenchymal Stem Cell Transplantation , Mesenchymal Stem Cells , Metabolism , Myocardial Infarction , Metabolism , Pathology , Neovascularization, Physiologic , Rats, Wistar , Transfection , Vascular Endothelial Growth Factor A , Genetics
4.
Journal of Central South University(Medical Sciences) ; (12): 373-378, 2005.
Article in English | WPRIM | ID: wpr-813556

ABSTRACT

OBJECTIVE@#To establish a cell line stably expressing the tissue plasminogen activator (TPA) in human skin fibroblasts so as to develop the function analysis and gene therapy of TPA in ischemic heart diseases.@*METHODS@#Eukaryotic expression vector pcDNA3.1(+) TPA was constructed and transferred into human skin fibroblasts. After G418 selection, the exogenous expression and activity of TPA were observed subsequently by reverse transcription-polymerase chain reaction (RT-PCR), enzyme-linked immunosorbent assay (ELISA), and chromogenic substrate assay.@*RESULTS@#Eukaryotic expression vector pcDNA3.1(+) TPA was expressed effectively in human skin fibroblasts. Quantitative ELISA showed that the expression of TPA protein of the experiment group was much higher than that of the control group (643.5 ng/10(6) cells per 24 hours vs. 19.2 ng/10(6) cells per 24 hours). And the chromogenic substrate assay showed that the exogenous TPA activity of the experimental group was also much higher than that of the control group (122.6 U/10(6) cells per 24 hours vs. 5.8 U/10(6) cells per 24 hours).@*CONCLUSION@#The exogenous TPA gene can be expressed effectively after pcDNA3.1(+)TPA was transferred into human skin fibroblasts, suggesting that the cell model will become an important tool in the further study of TPA function and gene therapy in ischemic heart diseases.


Subject(s)
Humans , Base Sequence , Cell Line , DNA, Complementary , Eukaryotic Cells , Metabolism , Fibroblasts , Metabolism , Genetic Therapy , Genetic Vectors , Molecular Sequence Data , Skin , Cell Biology , Tissue Plasminogen Activator , Genetics
SELECTION OF CITATIONS
SEARCH DETAIL